TNFSF11 and Peri-Implantitis: As peri-implantitis is characterized by progressive bone destruction, the reduction in RANKL level, which is involved in osteoclast activation [49], until the 6th month in both treatment groups may indicate a decrease in bone loss in the peri-implantitis area.